Global Gastrointestinal Drugs Market - Market Size, Share & Industry Trends, Growth Analysis Report By Drug Class, By Route of Administration, By Disorder Type, By Distribution Channel and Forecast 2019 - 2025


DescriptionTable of ContentList of TablesList of Figures
Introduction
Gastrointestinal Drugs Market was valued at USD XX Billion in 2019 and is projected to reach USD XX billion by 2025, at a CAGR of XX% from 2020-2025. Due to changing lifestyles, increasing geriatric population, Gastrointestinal Drugs Market is on a rise. Additionally, increasing prevalence of gastrointestinal diseases and rising investment in R&D, approval of new drugs, are also major driving factors for the Gastrointestinal Drugs Market.
On the other hand, high raw material costs, increasing presence of counterfeit drugs, are some of the restraining factor for this Market. 
Geographical Overview
At a global level, the North America region was holding the highest market share in 2019, due to reimbursement policies, increasing geriatric population. Europe is holding second position after North America. Whereas, Asia Pacific region is considered the fastest-growing region with key players adopting expansion strategy in this region to gain maximum market share in the coming years. Key factors such as improving healthcare infrastructure, increasing investment in R&D, are driving Gastrointestinal Drugs Market in the Asia Pacific region.
?
Segmental Overview
Gastrointestinal Drugs Market is segmented as per below specifications -  
By Drug Class: 
• Acid Neutralizers
o Antacids
o H2 Antagonists
o Proton Pump Inhibitors
• Antidiarrheal and Laxatives
• Antiemetic and Antinauseants
• Anti-inflammatory Drugs
• Biologics
• Antispasmodic
By Route of Administration: 
• Oral
• Parenteral
• Rectal
By Disorder Type:
• Gastro-esophageal Reflux Disease
• Inflammatory Bowel Disease
• Irritable Bowel Syndrome
By Distribution Channel: 
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Competitor Analysis
Gastrointestinal Drugs Market has presence of some of the key major players across globe which includes
• Bayer AG
• Takeda Pharmaceuticals
• Allergen PLC
• Novo Nordisk A/S
• AstraZeneca PLC
• AbbVie Inc.
• Johnson & Johnson
• Valeant Pharmaceuticals
• GlaxoSmithKline PLC
• Sanofi
• Janssen Biotech Inc.
These key players are concentrating its efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share, companies are adopting merger/ acquisition/ partnership and maintaining strong distribution networks strategies.  
By Geographical Locations: 
• North America
o U.S.
o Canada
• Europe
o U.K.
o France
o Italy
o Germany
o Spain
o Russia & CIS
o Rest of Europe
• Asia-Pacific
o China 
o India
o Japan
o South Korea
o ASEAN
o Rest of Asia Pacific 
• Latin America
o Brazil
o Argentina
o Rest of LATAM
• Middle East & Africa
o UAE
o South Africa
o Rest of MEA
Highlights of the report
What is Gastrointestinal Drugs Market?
Who all are key market players in the industry?
How the Parent Industry is growing?
Where are the key opportunities for new market entrant?
A comprehensive analysis, which covers key growth factors across the value chain
Recent developments in market
Granular Market Segmentation 
Market size projection based on Historical & current market trends 
Market share analysis and key strategies adopted by leading players
Production Cost & Sensitivity Analysis
Country Level Market Analysis of Top 16 countries
Data Driven Decision Recommendations